Table of Content

1 Measles Vaccine Market Overview
1.1 Measles Vaccine Product Overview
1.2 Measles Vaccine Market Segment by Type
1.2.1 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.2 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Global Measles Vaccine Market Size by Type
1.3.1 Global Measles Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Measles Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Measles Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Measles Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Measles Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Measles Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Measles Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Measles Vaccine Sales Breakdown by Type (2018-2024)
2 Global Measles Vaccine Market Competition by Company
2.1 Global Top Players by Measles Vaccine Sales (2018-2024)
2.2 Global Top Players by Measles Vaccine Revenue (2018-2024)
2.3 Global Top Players by Measles Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Measles Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Measles Vaccine Market Competitive Situation and Trends
2.5.1 Measles Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Measles Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Measles Vaccine Market
2.8 Key Manufacturers Measles Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Measles Vaccine Status and Outlook by Region
3.1 Global Measles Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Measles Vaccine Historic Market Size by Region
3.2.1 Global Measles Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Measles Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Measles Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Measles Vaccine Forecasted Market Size by Region
3.3.1 Global Measles Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Measles Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Measles Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Measles Vaccine by Application
4.1 Measles Vaccine Market Segment by Application
4.1.1 Children
4.1.2 Adults
4.2 Global Measles Vaccine Market Size by Application
4.2.1 Global Measles Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Measles Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Measles Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Measles Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Measles Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Measles Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Measles Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Measles Vaccine Sales Breakdown by Application (2018-2024)
5 North America Measles Vaccine by Country
5.1 North America Measles Vaccine Historic Market Size by Country
5.1.1 North America Measles Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Measles Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Measles Vaccine Sales in Value by Country (2018-2024)
5.2 North America Measles Vaccine Forecasted Market Size by Country
5.2.1 North America Measles Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Measles Vaccine Sales in Value by Country (2024-2034)
6 Europe Measles Vaccine by Country
6.1 Europe Measles Vaccine Historic Market Size by Country
6.1.1 Europe Measles Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Measles Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Measles Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Measles Vaccine Forecasted Market Size by Country
6.2.1 Europe Measles Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Measles Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Measles Vaccine by Region
7.1 Asia-Pacific Measles Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Measles Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Measles Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Measles Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Measles Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Measles Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Measles Vaccine Sales in Value by Region (2024-2034)
8 Latin America Measles Vaccine by Country
8.1 Latin America Measles Vaccine Historic Market Size by Country
8.1.1 Latin America Measles Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Measles Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Measles Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Measles Vaccine Forecasted Market Size by Country
8.2.1 Latin America Measles Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Measles Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Measles Vaccine by Country
9.1 Middle East and Africa Measles Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Measles Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Measles Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Measles Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Measles Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Measles Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Measles Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Measles Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Information
10.2.2 Sanofi-Pasteur Introduction and Business Overview
10.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi-Pasteur Measles Vaccine Products Offered
10.2.5 Sanofi-Pasteur Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Measles Vaccine Products Offered
10.3.5 Merck Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Novartis Measles Vaccine Products Offered
10.4.5 Novartis Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer Measles Vaccine Products Offered
10.5.5 Pfizer Recent Development
10.6 Serum Institute of India
10.6.1 Serum Institute of India Company Information
10.6.2 Serum Institute of India Introduction and Business Overview
10.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Serum Institute of India Measles Vaccine Products Offered
10.6.5 Serum Institute of India Recent Development
10.7 China National Biotech Group
10.7.1 China National Biotech Group Company Information
10.7.2 China National Biotech Group Introduction and Business Overview
10.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 China National Biotech Group Measles Vaccine Products Offered
10.7.5 China National Biotech Group Recent Development
10.8 Bavarian Nordic
10.8.1 Bavarian Nordic Company Information
10.8.2 Bavarian Nordic Introduction and Business Overview
10.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bavarian Nordic Measles Vaccine Products Offered
10.8.5 Bavarian Nordic Recent Development
10.9 Emergent Biosolutions
10.9.1 Emergent Biosolutions Company Information
10.9.2 Emergent Biosolutions Introduction and Business Overview
10.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Emergent Biosolutions Measles Vaccine Products Offered
10.9.5 Emergent Biosolutions Recent Development
10.10 Medimmune
10.10.1 Medimmune Company Information
10.10.2 Medimmune Introduction and Business Overview
10.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Medimmune Measles Vaccine Products Offered
10.10.5 Medimmune Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Company Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Johnson & Johnson Measles Vaccine Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 CSL Limited
10.12.1 CSL Limited Company Information
10.12.2 CSL Limited Introduction and Business Overview
10.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 CSL Limited Measles Vaccine Products Offered
10.12.5 CSL Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Measles Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Measles Vaccine Industrial Chain Analysis
11.4 Measles Vaccine Market Dynamics
11.4.1 Measles Vaccine Industry Trends
11.4.2 Measles Vaccine Market Drivers
11.4.3 Measles Vaccine Market Challenges
11.4.4 Measles Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Measles Vaccine Distributors
12.3 Measles Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Mumps Measles Rubella Vaccine, Live (MMR-II)
Table 2. Major Company of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Table 3. Global Measles Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Measles Vaccine Sales by Type (2018-2024) & (K MT)
Table 5. Global Measles Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Measles Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Measles Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Measles Vaccine Price by Type (2018-2024) & (USD/MT)
Table 9. Global Measles Vaccine Sales by Type (2024-2034) & (K MT)
Table 10. Global Measles Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Measles Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Measles Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Measles Vaccine Price by Type (2024-2034) & (USD/MT)
Table 14. North America Measles Vaccine Sales by Type (2018-2024) & (K MT)
Table 15. North America Measles Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Measles Vaccine Sales (K MT) by Type (2018-2024)
Table 17. Europe Measles Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Measles Vaccine Sales (K MT) by Type (2018-2024)
Table 19. Asia-Pacific Measles Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Measles Vaccine Sales (K MT) by Type (2018-2024)
Table 21. Latin America Measles Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Measles Vaccine Sales (K MT) by Type (2018-2024)
Table 23. Middle East and Africa Measles Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Measles Vaccine Sales by Company (2018-2024) & (K MT)
Table 25. Global Measles Vaccine Sales Share by Company (2018-2024)
Table 26. Global Measles Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Measles Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Measles Vaccine Price by Company (2018-2024) & (USD/MT)
Table 29. Global Measles Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Measles Vaccine Market
Table 33. Key Manufacturers Measles Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Measles Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Measles Vaccine Sales by Region (2018-2024) & (K MT)
Table 37. Global Measles Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Measles Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Measles Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 41. Global Measles Vaccine Sales by Region (2024-2034) & (K MT)
Table 42. Global Measles Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Measles Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Measles Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 46. Global Measles Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Measles Vaccine Sales by Application (2018-2024) & (K MT)
Table 48. Global Measles Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Measles Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Measles Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Measles Vaccine Price by Application (2018-2024) & (USD/MT)
Table 52. Global Measles Vaccine Sales by Application (2024-2034) & (K MT)
Table 53. Global Measles Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Measles Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Measles Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Measles Vaccine Price by Application (2024-2034) & (USD/MT)
Table 57. North America Measles Vaccine Sales by Application (2018-2024) (K MT)
Table 58. North America Measles Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Measles Vaccine Sales by Application (2018-2024) (K MT)
Table 60. Europe Measles Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Measles Vaccine Sales by Application (2018-2024) (K MT)
Table 62. Asia-Pacific Measles Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Measles Vaccine Sales by Application (2018-2024) (K MT)
Table 64. Latin America Measles Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Measles Vaccine Sales by Application (2018-2024) (K MT)
Table 66. Middle East and Africa Measles Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Measles Vaccine Sales by Country (2018-2024) & (K MT)
Table 68. North America Measles Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Measles Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Measles Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Measles Vaccine Sales by Country (2024-2034) & (K MT)
Table 72. North America Measles Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Measles Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Measles Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Measles Vaccine Sales by Country (2018-2024) & (K MT)
Table 76. Europe Measles Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Measles Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Measles Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Measles Vaccine Sales by Country (2024-2034) & (K MT)
Table 80. Europe Measles Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Measles Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Measles Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Measles Vaccine Sales by Region (2018-2024) & (K MT)
Table 84. Asia-Pacific Measles Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Measles Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Measles Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Measles Vaccine Sales by Region (2024-2034) & (K MT)
Table 88. Asia-Pacific Measles Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Measles Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Measles Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Measles Vaccine Sales by Country (2018-2024) & (K MT)
Table 92. Latin America Measles Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Measles Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Measles Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Measles Vaccine Sales by Country (2024-2034) & (K MT)
Table 96. Latin America Measles Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Measles Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Measles Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Measles Vaccine Sales by Country (2018-2024) & (K MT)
Table 100. Middle East and Africa Measles Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Measles Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Measles Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Measles Vaccine Sales by Country (2024-2034) & (K MT)
Table 104. Middle East and Africa Measles Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Measles Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Measles Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. GSK Company Information
Table 108. GSK Introduction and Business Overview
Table 109. GSK Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. GSK Measles Vaccine Product
Table 111. GSK Recent Development
Table 112. Sanofi-Pasteur Company Information
Table 113. Sanofi-Pasteur Introduction and Business Overview
Table 114. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Sanofi-Pasteur Measles Vaccine Product
Table 116. Sanofi-Pasteur Recent Development
Table 117. Merck Company Information
Table 118. Merck Introduction and Business Overview
Table 119. Merck Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Merck Measles Vaccine Product
Table 121. Merck Recent Development
Table 122. Novartis Company Information
Table 123. Novartis Introduction and Business Overview
Table 124. Novartis Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Novartis Measles Vaccine Product
Table 126. Novartis Recent Development
Table 127. Pfizer Company Information
Table 128. Pfizer Introduction and Business Overview
Table 129. Pfizer Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. Pfizer Measles Vaccine Product
Table 131. Pfizer Recent Development
Table 132. Serum Institute of India Company Information
Table 133. Serum Institute of India Introduction and Business Overview
Table 134. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Serum Institute of India Measles Vaccine Product
Table 136. Serum Institute of India Recent Development
Table 137. China National Biotech Group Company Information
Table 138. China National Biotech Group Introduction and Business Overview
Table 139. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. China National Biotech Group Measles Vaccine Product
Table 141. China National Biotech Group Recent Development
Table 142. Bavarian Nordic Company Information
Table 143. Bavarian Nordic Introduction and Business Overview
Table 144. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. Bavarian Nordic Measles Vaccine Product
Table 146. Bavarian Nordic Recent Development
Table 147. Emergent Biosolutions Company Information
Table 148. Emergent Biosolutions Introduction and Business Overview
Table 149. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. Emergent Biosolutions Measles Vaccine Product
Table 151. Emergent Biosolutions Recent Development
Table 152. Medimmune Company Information
Table 153. Medimmune Introduction and Business Overview
Table 154. Medimmune Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 155. Medimmune Measles Vaccine Product
Table 156. Medimmune Recent Development
Table 157. Johnson & Johnson Company Information
Table 158. Johnson & Johnson Introduction and Business Overview
Table 159. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 160. Johnson & Johnson Measles Vaccine Product
Table 161. Johnson & Johnson Recent Development
Table 162. CSL Limited Company Information
Table 163. CSL Limited Introduction and Business Overview
Table 164. CSL Limited Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 165. CSL Limited Measles Vaccine Product
Table 166. CSL Limited Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Measles Vaccine Market Trends
Table 170. Measles Vaccine Market Drivers
Table 171. Measles Vaccine Market Challenges
Table 172. Measles Vaccine Market Restraints
Table 173. Measles Vaccine Distributors List
Table 174. Measles Vaccine Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles Vaccine Product Picture
Figure 2. Global Measles Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Measles Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Measles Vaccine Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Mumps Measles Rubella Vaccine, Live (MMR-II)
Figure 6. Global Mumps Measles Rubella Vaccine, Live (MMR-II) Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Figure 8. Global Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Global Measles Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Measles Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Measles Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Measles Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Measles Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Measles Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Measles Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Measles Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Measles Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Measles Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Measles Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Measles Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Measles Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Measles Vaccine Revenue in 2022
Figure 23. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Children
Figure 25. Global Children Sales YoY Growth (2018-2034) & (K MT)
Figure 26. Product Picture of Adults
Figure 27. Global Adults Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Global Measles Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Measles Vaccine Sales Market Share by Application in 2022 & 2034
Figure 30. North America Measles Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Measles Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Measles Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Measles Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Measles Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Measles Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Measles Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Measles Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Measles Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Measles Vaccine Manufacturing Cost Structure
Figure 41. Measles Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed